Bookmark
Forward
Explore Literature Results
QuickView for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=1D75C74D5C77A9BAC3E0BBC789397CA4;jsessionid=C855386F3FC95269E723E7516712C4E6;jsessionid=8D050235A3ED20AA8378B960E5DDCEAF;jsessionid=CE85614A0FBD1BBFC869B51BCA6DE828 (gene)
Most Correlated Studies
There were no matches for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=1D75C74D5C77A9BAC3E0BBC789397CA4;jsessionid=C855386F3FC95269E723E7516712C4E6;jsessionid=8D050235A3ED20AA8378B960E5DDCEAF;jsessionid=CE85614A0FBD1BBFC869B51BCA6DE828
Explore Curated Studies Results
Most Relevant Literature
- AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistan…
- Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.
- Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Mat…
- A chemical compound inhibiting the Aha1-Hsp90 chaperone complex.
- Cooperative Nucleotide Binding in Hsp90 and Its Regulation by Aha1.
Most Relevant Clinical Trials
There were no clinical trials for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=1D75C74D5C77A9BAC3E0BBC789397CA4;jsessionid=C855386F3FC95269E723E7516712C4E6;jsessionid=8D050235A3ED20AA8378B960E5DDCEAF;jsessionid=CE85614A0FBD1BBFC869B51BCA6DE828
Explore Clinical Trials Results
